Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
With a market cap of 23.15B, Incyte(INCY) trades at $114.23. The stock has a price-to-earnings ratio of 14.69.
During the trading session on 2026-10-05, Incyte(INCY) shares reached a daily high of $115.78 and a low of $112.86. At a current price of $114.23, the stock is +1.2% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 1.07M, compared to an average daily volume of 1.64M.
The stock's 52-week range extends from a low of $82.82 to a high of $132.60.
The stock's 52-week range extends from a low of $82.82 to a high of $132.60.
INCY News
Stifel analyst Stephen Willey raised the firm’s price target on Incyte (INCY) to $157 from $145 and keeps a Buy rating on the shares after having hosted a serie...
...
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY Quick QuoteINCY - Free Report) and Techne (TECH Qui...
Analyst ratings
52%
of 31 ratingsMore INCY News
Mirum Pharmaceuticals and Incyte reported that the FDA approved Atebrioz (zilurgisertib), an oral ALK2 inhibitor for Fibrodysplasia Ossificans Progressiva in pa...
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Incyte, with a price target of $152.00. Mitchell Kapoor has given hi...
Incyte (INCY) moved back into focus after the U.S. FDA cleared Atebrioz tablets for fibrodysplasia ossificans progressiva and granted the company a Rare Pediatr...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.